medigraphic.com
SPANISH

Revista del Centro Dermatológico Pascua

ISSN 1405-1710 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 2-3

<< Back Next >>

Rev Cent Dermatol Pascua 2020; 29 (2-3)

Calciphylaxis. Case report

Jiménez-Hernández F, Baldassarri-Ortego LF, Álvarez-Rivero V
Full text How to cite this article 10.35366/99919

DOI

DOI: 10.35366/99919
URL: https://dx.doi.org/10.35366/99919

Language: Spanish
References: 14
Page: 77-80
PDF size: 254.41 Kb.


Key words:

Calciphylaxis, chronic ulcers, chronic kidney disease, peritoneal dialysis.

ABSTRACT

Calciphylaxis is a condition caused by the ischemia and necrosis of dermis and subcutaneous tissue in patients undergoing dialysis due to chronic kidney disease. It is clinically characterized by chronic, painful-non healing ulcers. The prognosis is rather bleak. In this article, we present the case and evolution of a 58 year old, female patient with the diagnosis of calciphylaxis secondary to chronic kidney disease.


REFERENCES

  1. Saito T, Mima Y, Sugiyama M, Miyazawa N, Iida A, Kanazawa N et al. Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility. CEN Case Rep. 2019; (0123456789). Available in: https://doi.org/10.1007/s13730-019-00439-8.

  2. Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008; 3: 1139-1143.

  3. Nigwekar SU. Calciphylaxis. Curr Opin Nephrol Hypertens. 2017; 26: 276-281.

  4. Gaisne R, Péré M, Menoyo V, Hourmant M, Larmet-Burgeot D. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study. BMC Nephrol. 2020; 21: 1-11.

  5. Seethapathy H, Noureddine L. Calciphylaxis: approach to diagnosis and management. Adv Chronic Kidney Dis. 2019; 26: 484-490. Available in: https://doi.org/10.1053/j.ackd.2019.09.005.

  6. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018; 378: 1704-1714.

  7. García-Lozano JA, Ocampo-Candiani J, Martínez-Cabriales SA, Garza-Rodríguez V. An update on calciphylaxis. Am J Clin Dermatol. 2018; 19: 599-608.

  8. Meegada S, Annakula M, Challa T, Peddi P. Calciphylaxis: a deceiving cellulitis. Cureus. 2019; 11: e6518.

  9. Colboc H, Moguelet P, Bazin D, Carvalho P, Dillies AS, Chaby G et al. Localization, morphologic features, and chemical composition of calciphylaxis-related skin deposits in patients with calcific uremic arteriolopathy. JAMA Dermatology. 2019; 155: 789-796.

  10. Musso CG, Enz PA, Kowalczuk A, Cozzolino M, Brandenburg V, Nigwekar S. Differential diagnosis of calciphylaxis in chronic dialysis patients. Int Urol Nephrol. 2020; 52: 595-597. Available in: https://doi.org/10.1007/s11255-020-02388-z.

  11. Faizi N, Kazmi S. Universal health coverage. There is more to it than meets the eye. J Fam Med Prim Care. 2017; 6: 169-170. Available in: http://www.jfmpc.com/article.asp?issn=2249-4863;year=2017;volume=6;issue=1;spage=169;epage=170;aulast=Faizi.

  12. Herrera-Martínez Y, Martín-Marcuartu JJ, Mohigefer-Barrera J, Jiménez-Hoyuela JM, García-Jiménez R. Imagen híbrida (SPECT/TC) en el diagnóstico precoz de un paciente con calcifilaxis. Nefrología. 2020; 40: 576-578. Available in: https://doi.org/10.1016/j.nefro.2019.11.003.

  13. Dado DN, Huang B, Foster DV, Nielsen JS, Gurney JM, Morrow BD et al. Management of calciphylaxis in a burn center: a case series and review of the literature. Burns. 2019; 45: 241-246. Available in: https://doi.org/10.1016/j.burns.2018.09.008.

  14. Chang JJ. Calciphylaxis: diagnosis, pathogenesis and treatment. Adv Skin Wound Care. 2019; 32: 205-215.




Figure 1
Figure 2
Figure 3

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cent Dermatol Pascua. 2020;29